Cited by 1,743Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesNF-κB Signaling Pathways

The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.

STATs in oncogenesis

Bowman, Tammy, Garcia, Roy, Turkson, James, Jove, Richard·2000·Oncogene

DOI 10.1038/sj.onc.1203527

Open this paper in CoChat — free account

Abstract

Since their discovery as key mediators of cytokine signaling, considerable progress has been made in defining the structure-function relationships of Signal Transducers and Activators of Transcription (STATs). In addition to their central roles in normal cell signaling, recent studies have demonstrated that diverse oncoproteins can activate specific STATs (particularly Stat3 and Stat5) and that constitutively-activated STAT signaling directly contributes to oncogenesis. Furthermore, extensive surveys of primary tumors and cell lines derived from tumors indicate that inappropriate activation of specific STATs occurs with surprisingly high frequency in a wide variety of human cancers. Together, these findings provide compelling evidence that aberrant STAT activation associated with oncogenesis is not merely adventitious but instead contributes to the process of malignant transformation. These studies are beginning to reveal the molecular mechanisms leading to STAT activation in the context of oncogenesis, and candidate genes regulated by STATs that may contribute to oncogenesis are being identified. Recent studies suggest that activated STAT signaling participates in oncogenesis by stimulating cell proliferation and preventing apoptosis. This review presents the evidence for critical roles of STATs in oncogenesis and discusses the potential for development of novel cancer therapies based on mechanistic understanding of STAT signaling. Oncogene (2000).

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1203527

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656

Show all 152 references

Research works printed but not linked: 7

Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . 1996 Blood 87: 1692–1697 · DOI
Hallek M, Leif Bergsagel P and Anderson KC . 1998 Blood 91: 3–21 · DOI
Ho JM, Beattie BK, Squire JA, Frank DA and Barber DL . 1999 Blood 93: 4354–4364 · DOI
Liu RY, Fan C, Garcia R, Jove R and Zuckerman KS . 1999 Blood 93: 2369–2379 · DOI
Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B and Calabretta B . 1998 Blood 91: 406–418 · DOI
Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC and Rosen ST . 1998 Blood 91: 570–576 · DOI
Wang YH, Wharton W, Garcia R, Kraker A, Jove R and Pledger WJ . 2000 Oncogene in press

Sorted by citations

Items 701–800 of 999

MicroRNA-302b Suppresses Human Epithelial Ovarian Cancer Cell Growth by Targeting RUNX1
Ge, T., Yin, M., Yang, M., Liu, T., & Lou, G. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000369664 · Cited by 53
Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: Structural recognition of STAT SH2 domains
Gunning, P. T., Katt, W. P., Glenn, M. P., Siddiquee, K., Kim, J. S., Jove, R., Sebti, S. M., Turkson, J., & Hamilton, A. D. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.077 · Cited by 53
Self-citation
Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: Identification of the c-myc regulatory gene network
Reymann, S., & Borlak, J. T. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-46 · Cited by 53
Sulforaphane (SFN): An Isothiocyanate in a Cancer Chemoprevention Paradigm
Ullah, M. (2015) · Medicines · doi:10.3390/medicines2030141 · Cited by 56
Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours
Lai, R. L., Rassidakis, G. Z., Medeiros, L. J., Leventaki, V., Keating, M., & McDonnell, T. J. (2002) · The Journal of Pathology · doi:10.1002/path.1253 · Cited by 53
Opposing roles for Drosophila JAK/STAT signalling during cellular proliferation
Mukherjee, T., Hombría, J. C., & Zeidler, M. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208487 · Cited by 53
Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motif
Shao, H., Xu, X., Mastrangelo, M.-A. A., Jing, N., Cook, R. G., Legge, G. B., & Tweardy, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314037200 · Cited by 53
Ataxia Telangiectasia Mutated Proteins, MAPKs, and RSK2 Are Involved in the Phosphorylation of STAT3
Zhang, Y., Cho, Y., Petersen, B. L., Bode, A. M., Zhu, F., & Dong, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210368200 · Cited by 55
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene
Shan, L. (2002) · Carcinogenesis · doi:10.1093/carcin/23.10.1561 · Cited by 53
STAT3 pathway as a molecular target for resveratrol in breast cancer treatment
Kohandel, Z., Farkhondeh, T., Aschner, M., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02179-1 · Cited by 51
Role of adiponectin and its receptors in cancer.
Obeid, S., & Hebbard, L. (2012) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2012.04.001 · Cited by 54
WT1 Promotes Cell Proliferation in Non-Small Cell Lung Cancer Cell Lines through Up-Regulating Cyclin D1 and p-pRb In Vitro and In Vivo
Xu, C., Wu, C. H., Xia, Y., Zhong, Z., Liu, X., Xu, J., Cui, F., Chen, B., Røe, O. D., Li, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068837 · Cited by 53
Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells
Chen, Z., Huang, C., Yang, Y., Ding, Y., Ouyang, H., Zhang, Y., & Xu, M. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.164 · Cited by 52
Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
Min, H., & Wei‐hong, Z. (2009) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01045.x · Cited by 53
Antagonism of the Stat3–Stat3 Protein Dimer with Salicylic Acid Based Small Molecules
Fletcher, S., Page, B. D. G., Zhang, X., Yue, P., Li, Z. H., Sharmeen, S., Singh, J., Zhao, W. M., Schimmer, A. D., Trudel, S., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100194 · Cited by 52
Self-citation
HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
Togi, S., Kamitani, S., Kawakami, S., Ikeda, O., Muromoto, R., Nanbo, A., & Matsuda, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.132 · Cited by 52
Atmospheric particulate matter (PM10) exposure-induced cell cycle arrest and apoptosis evasion through STAT3 activation via PKCζ and Src kinases in lung cells
Reyes-Zárate, E., Sánchez-Pérez, Y., Gutiérrez‐Ruíz, M. C., Chirino, Y. I., Osornio-Vargas, Á. R., Morales‐Bárcenas, R., Souza-Arroyo, V., & García-Cuellar, C. M. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.04.072 · Cited by 52
MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
Toll, A., Salgado, R., Espinet, B., Díaz‐Lagares, Á., Hernández-Ruiz, E., Andrades, E., Sandoval, J., Esteller, M., Pujol, R. M., & Hernández‐Muñoz, I. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0537-z · Cited by 54
Updating interleukin‐6 classic‐ and trans‐signaling
Scheller, J., Grötzinger, J., & Rose‐John, S. (2006) · Signal Transduction · doi:10.1002/sita.200600086 · Cited by 53
Targeted Disruption of Stat3 Reveals a Major Role for Follicular Stem Cells in Skin Tumor Initiation
Kim, D. J., Kataoka, K., Rao, D., Kiguchi, K., Cotsarelis, G., & DiGiovanni, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1180 · Cited by 52
STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line
Baus, D., Nonnenmacher, F., Jankowski, S., Döring, C., Bräutigam, C., Frank, M., Hansmann, M.-L., & Pfitzner, E. (2009) · Leukemia · doi:10.1038/leu.2009.103 · Cited by 52
STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation
Ikeda, O., Miyasaka, Y., Sekine, Y., Mizushima, A., Muromoto, R., Nanbo, A., Yoshimura, A., & Matsuda, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.076 · Cited by 52
Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: The role of p53 and p21
Escandell, J. M., Kaler, P., Recio, M. C., Sasazuki, T., Shirasawa, S., Augenlicht, L. H., Rı́os, J.-L., & Klampfer, L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.004 · Cited by 52
Nuclear β-Arrestin1 Functions as a Scaffold for the Dephosphorylation of STAT1 and Moderates the Antiviral Activity of IFN-γ
Mo, W., Zhang, L., Yang, G., Zhai, J., Hu, Z., Chen, Y., Chen, X., Hui, L., Huang, R., & Hu, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.017 · Cited by 51
TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3
Pery, E., Tsruya, R., Levitsky, P., Pomp, O., Taler, M., Weisberg, S., Parris, W. E., Kulkarni, S., Malovani, H., Pawson, T. J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208149 · Cited by 51
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer
Khong, T. L., Thairu, N., Larsen, H., Dawson, P. M., Kiriakidis, S., & Paleolog, E. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-518 · Cited by 54
Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line
Chichiarelli, S., Gaucci, E., Ferraro, A., Grillo, C., Fabio Altieri, F., Cocchiola, R., Arcangeli, V., Turano, C., & Eufemi, M. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.12.004 · Cited by 50
Targeting miR-21 in glioma: a small RNA with big potential
Moore, L. M., & Zhang, W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.527334 · Cited by 51
Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning
Matsumoto, T., O’Malley, K. A., Efron, P. A., Burger, C., McAuliffe, P. F., Scumpia, P. O., Uchida, T., Tschoeke, S. K., Fujita, S., Moldawer, L. L., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.04.010 · Cited by 51
STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1
Wang, Z., Zhu, S., Shen, M., Liu, J., Wang, M., Li, C., Wang, Y., Deng, A., & Mei, Q. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs361 · Cited by 51
Icariin exerts inhibitory effects on the growth and metastasis of KYSE70 human esophageal carcinoma cells via PI3K/AKT and STAT3 pathways
Gu, Z., Zhang, Z.-T., Wang, J., & Xu, B. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.06.004 · Cited by 51
Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt‐phosphorylation and up‐regulation of 14‐3‐3
Slaets, H., Dumont, D., Vanderlocht, J., Noben, J., Leprince, P., Robben, J., Hendriks, J. J. A., Stinissen, P., & Hellings, N. (2008) · PROTEOMICS · doi:10.1002/pmic.200700641 · Cited by 51
CPAP Is a Novel Stat5-Interacting Cofactor that Augments Stat5-Mediated Transcriptional Activity
Peng, B. H., Sutherland, K. D., Sum, E. Y. M., Olayioye, M. A., Wittlin, S., Tang, T. K., Lindeman, G. J., & Visvader, J. E. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0108 · Cited by 51
Myc Down-regulation as a Mechanism to Activate the Rb Pathway in STAT5A-induced Senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., Huot, G., & Ferbeyre, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707074200 · Cited by 51
Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation
Kim, K. W., Mutter, R. W., Cao, C., Albert, J. M., Shinohara, E. T., Sekhar, K. R., & Lü, B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0261 · Cited by 52
RETRACTED: Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice
DeMiguel, F., Lee, S. O., Lou, W., Xiao, X., Pflug, B. R., Nelson, J. B., & Gao, A. C. (2002) · The Prostate · doi:10.1002/pros.10110 · Cited by 51
Retracted
Hypothesis: Cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells?
Prindull, G. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.03.002 · Cited by 51
Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells
Tkach, M., Coria, L. M., Rosemblit, C., Rivas, M. A., Proietti, C. J., Flaqué, M. C. D., Béguelin, W., Frahm, I., Charreau, E. H., Cassataro, J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102538 · Cited by 50
Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation
Carpi, A., Nicolini, A., Antonelli, A., Ferrari, P., & Rossi, G. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909790192392 · Cited by 49
Gambogic Acid Inhibits STAT3 Phosphorylation through Activation of Protein Tyrosine Phosphatase SHP-1: Potential Role in Proliferation and Apoptosis
Prasad, S., Pandey, M. K., Yadav, V. R., & Aggarwal, B. B. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0340 · Cited by 50
Retracted
miR-21: A gene of dual regulation in breast cancer
Zhang, C., Liu, K., LI, T., Fang, J., Ding, Y., Sun, L., TU, T., JIANG, X., Du, S., Hu, J., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3232 · Cited by 52
Noradrenaline acting on astrocytic β2-adrenoceptors induces neurite outgrowth in primary cortical neurons
Day, J. S., O'Neill, E., Cawley, C. L., Aretz, N. K., Kilroy, D., Gibney, S. M., Harkin, A., & Connor, T. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.027 · Cited by 51
JAK‐STAT signaling pathway mediates astrogliosis in brains of scrapie‐infected mice
Na, Y., Jin, J., Kim, J., Choi, E., Carp, R. I., & Kim, Y. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04769.x · Cited by 50
Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells
Thomas, C. Y., Chouinard, M. L., Cox, M., Parsons, S. J., Stallings‐Mann, M. L., Garcia, R., Jove, R., & Wharen, R. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.10880 · Cited by 50
Self-citation
Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase
Sarcar, B., Ghosh, A. K., Steele, R., RAY, R. K., & Ray, R. B. (2004) · Virology · doi:10.1016/j.virol.2004.01.008 · Cited by 50
Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b
Shipley, J. M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.020 · Cited by 49
Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.
Mitchell, T. J., Whittaker, S. J., & John, S. (2003) · PubMed · Cited by 49
Interactions of STAP-2 with Brk and STAT3 Participate in Cell Growth of Human Breast Cancer Cells
Ikeda, O., Sekine, Y., Mizushima, A., Nakasuji, M., Miyasaka, Y., Yamamoto, C., Muromoto, R., Nanbo, A., Oritani, K., Yoshimura, A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162388 · Cited by 50
Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action
Chilampalli, C., Guillermo, R. F., Zhang, X., Kaushik, R. S., Young, A. J., Zeman, D., Hildreth, M. B., Fahmy, H. T. Y., & Dwivedi, C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-456 · Cited by 49
Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation
Liu, Y., Lv, L., Xiao, W., Gong, C., Yin, J., Wang, D., & Sheng, H. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0382-7 · Cited by 49
Short-type PB-cadherin promotes self-renewal of spermatogonial stem cells via multiple signaling pathways
Wu, J., Zhang, Y., Tian, G. G., Zou, K., Lee, C. M., Yu, Q., & Yuan, Z. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.011 · Cited by 49
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines
Yamatodani, T., Ekblad, L., Kjellén, E., Johnsson, A., Mineta, H., & Wennerberg, J. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0475-2 · Cited by 51
Phospho‐Stat3 expression and correlation with VEGF, p53, and Bcl‐2 in gastric carcinoma using tissue microarray
CHOI, J., Ahn, M., PARK, C., Han, H., Kwon, S.-J., LEE, Y., & Kim, I. S. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_401.x · Cited by 49
Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: Correlation with IL-6, VEGF and microvessel morphometry
Piperi, C., Samaras, V. D., Levidou, G., Kavantzas, N., Boviatsis, E. I., Petraki, K., Grivas, A., Barbatis, C., Varsos, V. G., Patsouris, E., et al. (2011) · Cytokine · doi:10.1016/j.cyto.2011.05.012 · Cited by 51
Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells
Tang, C., Xue, H.-L., Huang, H., & Wang, X.-G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.069 · Cited by 49
Selective effects of non-thermal atmospheric plasma on triple-negative breast normal and carcinoma cells through different cell signaling pathways
Liu, Y., Tan, S. H., Zhang, H., Kong, X., Ding, L., Shen, J., Yan, L., Cheng, C., Zhu, T., & Xia, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-08792-3 · Cited by 49
Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents
Gelain, A., Mori, M., Meneghetti, F., & Villa, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180719122729 · Cited by 49
Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells.
Ekmekçioglu, S., Ellerhorst, J. A., Mumm, J. B., Zheng, M., Broemeling, L. D., Prieto, V. G., Stewart, A. L., Mhashilkar, A. M., Chada, S., & Grimm, E. A. (2003) · PubMed · Cited by 49
Critical Role of STAT5 Activation in Transformation Mediated by ZNF198-FGFR1*
Heath, C., & Cross, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308743200 · Cited by 53
Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma
Manavi, M., Hudelist, G., Fink-Retter, A., Gschwandtler-Kaulich, D., Pischinger, K., & Czerwenka, K. F. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.12.032 · Cited by 48
The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition
Wang, X., Zhang, Y., ZHANG, X., Tian, W., Feng, W., & Chen, T. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1298 · Cited by 49
Search for a novel antioxidant, anti-inflammatory/analgesic or anti-proliferative drug: cucurbitacins hold the ace.
Bernard, S. A., & Oridupa, O. A. (2010) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9001120 · Cited by 48
EGFR Inhibition Induces Proinflammatory Cytokines via NOX4 in HNSCC
Fletcher, E. V. M., Love-Homan, L., Sobhakumari, A., Feddersen, C. R., Koch, A. T., Goel, A., & Simons, A. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0187 · Cited by 48
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
Krichevsky, A. M., & Uhlmann, E. J. (2019) · Neurotherapeutics · doi:10.1007/s13311-018-00702-3 · Cited by 48
Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling
Shaer, L. A., Walsby, E. J., Gilkes, A., Tonks, A. J., Walsh, V., Mills, K., Burnett, A. K., & Rowntree, C. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07053.x · Cited by 49
The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells
Baśkiewicz‐Masiuk, M., & Machaliński, B. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00242.x · Cited by 48
Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1
Zhang, Y. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh115 · Cited by 48
STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression
Joo, A., Aburatani, H., Morii, E., Iba, H., & Yoshimura, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207174 · Cited by 48
An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells.
Aaronson, D. S., Muller, M., Neves, S. R., Chung, W.-C., Jayaram, G., Iyengar, R., & Ram, P. T. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.02.006 · Cited by 47
STAT3 regulated ATR via microRNA-383 to control DNA damage to affect apoptosis in A431 cells
Liao, X., Zheng, L., He, H., Zheng, D., Wei, Z., Wang, N., Dong, J., Ma, W., & Zhang, T. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.08.005 · Cited by 48
JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein–protein interaction in human colon cancer cells
Nishimoto, A., Kugimiya, N., Hosoyama, T., Enoki, T., Li, T., & Hamano, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.105 · Cited by 47
Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model
Park, J., Han, C. R., Zhao, L., Willingham, M., & Cheng, S.-Y. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0417 · Cited by 42
CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity
Chen, R.-Y., Yen, C.-J., Liu, Y.-W., Guo, C.-G., Weng, C.-Y., Lai, C.-H., Wang, J., Lin, Y., & Hung, L. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0413-7 · Cited by 47
Stat3 Cleavage by Caspases
Darnowski, J. W., Goulette, F. A., Guan, Y. A., Chatterjee, D., Yang, Z., Cousens, L. P., & Chin, Y. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600088200 · Cited by 47
STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines
Zhou, W., Grandis, J. R., & Wells, A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603234 · Cited by 47
Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
Oshiro, M. M., Landowski, T. H., Catlett-Falcone, R., Hazlehurst, L., Huang, M., Jove, R., & Dalton, W. S. (2001) · PubMed · Cited by 46
Self-citation
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Ni, Y., Low, J. T., Silke, J., & O’Reilly, L. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835997 · Cited by 47
Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma
Boonjaraspinyo, S., Boonmars, T., Wu, Z., Loilome, W., Sithithaworn, P., Nagano, I., Pinlaor, S., Yongvanit, P., Nielsen, P. S., Pairojkul, C., et al. (2012) · Tumor Biology · doi:10.1007/s13277-012-0438-8 · Cited by 46
Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells
Joung, Y. H., Lim, E. J., Lee, M. Y., Park, J., Ye, S., Park, E. U., Kim, S. Y., Zhang, Z., Lee, K. J., Park, D. K., et al. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.45 · Cited by 46
JAK 2‐related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor‐activating mutation
Harada, D., Takigawa, N., Ochi, N., Ninomiya, T., Yasugi, M., Kubo, T., Takeda, H., Ichihara, E., Ohashi, K., Takata, S., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02363.x · Cited by 46
Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression
Cheong, J., Hong, S. Y., Zheng, Y., & Noh, S. H. (2011) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2011.11.1.16 · Cited by 46
GPRC5A: An Emerging Biomarker in Human Cancer
Jiang, X., Xu, X., Wu, M., Guan, Z., Su, X., Chen, S., Wang, H., & Teng, L. (2018) · BioMed Research International · doi:10.1155/2018/1823726 · Cited by 50
Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells
Lee, M. Y., Joung, Y. H., Lim, E. J., Park, J., Ye, S., Park, T., Zhang, Z., Park, D. K., Lee, K. J., & Yang, Y. M. (2005) · The Breast · doi:10.1016/j.breast.2005.05.005 · Cited by 48
Stat3 Expression in Oral Squamous Cell Carcinoma: Association with Clinicopathological Parameters and Survival
Shah, N. G., Trivedi, T. I., Tankshali, R. A., Goswami, J., Jetly, D., Kobawala, T. P., Shukla, S. N., Shah, P. M., & Verma, R. J. (2006) · The International Journal of Biological Markers · doi:10.1177/172460080602100307 · Cited by 47
Investigation of the protein alkylation sites of the STAT3:STAT3 inhibitor Stattic by mass spectrometry
Heidelberger, S., Zinzalla, G., Antonow, D., Essex, S., Piku Basu, B., Palmer, J., Husby, J., Jackson, P. J. M., Rahman, K. M., Wilderspin, A. F., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.066 · Cited by 52
Wilms' Tumor 1 and Signal Transducers and Activators of Transcription 3 Synergistically Promote Cell Proliferation: A Possible Mechanism in Sporadic Wilms' Tumor
Rong, Y., Cheng, L., Ning, H., Zou, J., Zhang, Y., Xu, F., Liu, L., Chang, Z., & Fu, X.-Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1172 · Cited by 45
Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4
Bard, J. D., Gélébart, P., Amin, H. M., Young, L. C., Ma, Y., & Lai, R. L. (2009) · The FASEB Journal · doi:10.1096/fj.08-117721 · Cited by 44
CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma
Lee, Y., Wu, W., Huang, C., Li, C., Li, W., Yeh, B., Liang, P., Wu, T., & Li, C. (2016) · Journal of Cancer · doi:10.7150/jca.14281 · Cited by 45
Novel Thiosemicarbazones Regulate the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway: Inhibition of Constitutive and Interleukin 6–Induced Activation by Iron Depletion
Lui, G. Y. L., Kovačević, Ž., Menezes, S. V., Kalinowski, D. S., Merlot, A. M., Sahni, S., & Richardson, D. R. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096529 · Cited by 45
Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells
Wu, J., Tang, Q., Yang, L., Chen, Y., Zheng, F., & Hann, S. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00626-6 · Cited by 47
Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis
Huang, W., Liu, Y., Wang, J., Yuan, X., Jin, H.-W., Zhang, L.-R., Zhang, J., Liu, Z.-M., & Cui, J.-R. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.037 · Cited by 45
Ganoderic acid A exerts antitumor activity against MDA‑MB‑231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
Yang, Y., Zhou, H., Liu, W., Wu, J., Yue, X., Wang, J., Quan, L., Liu, H., Guo, L., Wang, Z., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9475 · Cited by 45
STAT3beta, a distinct isoform from STAT3
Zhang, H., Yang, P.-L., Li, E., & Xu, L. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.006 · Cited by 45
Exosomes from Macrophages Exposed to Apoptotic Breast Cancer Cells Promote Breast Cancer Proliferation and Metastasis
Yu, X., Zhang, Q., Zhang, X., Han, Q., Li, H., Mao, Y., Wang, X., Guo, H., Irwin, D. M., Niu, G., et al. (2019) · Journal of Cancer · doi:10.7150/jca.31241 · Cited by 45
Physical and functional interactions between STAT3 and Kaposi's sarcoma‐associated herpesvirus‐encoded LANA
Muromoto, R., Okabe, K., Fujimuro, M., Sugiyama, K., Yokosawa, H., Seya, T., & Matsuda, T. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.11.057 · Cited by 46
Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells
Tomita, M., Kawakami, H., Uchihara, J., Okudaira, T., Masuda, M., Matsuda, T., Tanaka, Y., Ohshiro, K., & Mori, N. (2006) · Retrovirology · doi:10.1186/1742-4690-3-22 · Cited by 46
Retracted
Genetic, biochemical and evolutionary facets of Xmrk-induced melanoma formation in the fish Xiphophorus
Meierjohann, S., Schartl, M., & Volff, J. (2004) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cca.2004.06.002 · Cited by 45
Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein.
Lian, J. P., Word, B. R., Taylor, S., Hammons, G., & Lyn‐Cook, B. D. (2004) · PubMed · Cited by 45
Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
Lin, J., Jin, X., Rothman, K., Lin, H.-J., Tang, H., & Burke, W. M. (2002) · PubMed · Cited by 46
Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway
FANG, P., Hwa, V., & Rosenfeld, R. G. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.011 · Cited by 45

Authors: Bowman, T., Garcia, R., Turkson, J., & Jove, R.
Affiliations: Moffitt Cancer Center (US)
University of South Florida (US)
ORCID: Turkson, James
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2000-05-25
Volume: 19
Issue: 21
Pages: 2474-2488
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1203527
OpenAlex: W2024282024
Cited by: 1,743
References: 152
Citations by year: 2026: 16 · 2025: 18 · 2024: 18 · 2023: 22 · 2022: 39 · 2021: 48 · 2020: 44 · 2019: 45 · 2018: 59 · 2017: 63 · 2016: 58 · 2015: 104 · 2014: 80 · 2013: 82 · 2012: 89
FWCI: 7.25
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: STAT, signal transducer and activator of transcription, carcinogenesis, STAT3, STAT5, malignant transformation, cytokine signaling, cell proliferation, apoptosis, cancer therapy targets, cancer cell lines
MeSH terms: Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Neoplasms, Phosphorylation, Phosphoserine, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Neoplastic, STAT1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STATs in oncogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks